Torrent Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
106312.48 Cr.
|
P/BV
|
14.17
|
Book Value (Rs.)
|
221.73
|
52 Week High/Low (Rs.)
|
3591/2520
|
FV/ML
|
5/1
|
P/E(X)
|
64.18
|
Bookclosure
|
01/02/2025
|
EPS (Rs.)
|
48.94
|
Div Yield (%)
|
0.89
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 48.94 | 36.79 | 45.93 | 73.98 | 60.55 |
Diluted EPS (Rs.) | 48.94 | 36.79 | 45.93 | 73.98 | 60.55 |
Cash EPS (Rs.) | 72.82 | 57.67 | 85.05 | 112.84 | 99.21 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 202.57 | 183.13 | 351.75 | 344.90 | 284.99 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 202.57 | 183.13 | 351.75 | 344.90 | 284.99 |
Revenue From Operations / Share (Rs.) | 316.96 | 284.23 | 502.72 | 472.97 | 469.12 |
PBDIT / Share (Rs.) | 101.21 | 85.30 | 155.27 | 149.90 | 135.41 |
PBIT / Share (Rs.) | 77.33 | 64.43 | 116.15 | 111.04 | 96.74 |
PBT / Share (Rs.) | 69.49 | 54.58 | 72.44 | 90.18 | 70.11 |
Net Profit / Share (Rs.) | 48.94 | 36.79 | 45.92 | 73.97 | 60.55 |
NP After MI And SOA / Share (Rs.) | 48.94 | 36.79 | 45.92 | 73.97 | 60.55 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 31.93 | 30.01 | 30.88 | 31.69 | 28.86 |
PBIT Margin (%) | 24.39 | 22.66 | 23.10 | 23.47 | 20.62 |
PBT Margin (%) | 21.92 | 19.20 | 14.40 | 19.06 | 14.94 |
Net Profit Margin (%) | 15.44 | 12.94 | 9.13 | 15.63 | 12.90 |
NP After MI And SOA Margin (%) | 15.44 | 12.94 | 9.13 | 15.63 | 12.90 |
Return on Networth / Equity (%) | 24.15 | 20.09 | 13.05 | 21.44 | 21.24 |
Return on Capital Employeed (%) | 27.16 | 22.79 | 22.63 | 20.46 | 19.13 |
Return On Assets (%) | 10.99 | 8.29 | 5.93 | 8.89 | 7.31 |
Long Term Debt / Equity (X) | 0.23 | 0.40 | 0.35 | 0.50 | 0.67 |
Total Debt / Equity (X) | 0.57 | 0.85 | 0.67 | 0.82 | 0.90 |
Asset Turnover Ratio (%) | 0.71 | 0.68 | 0.53 | 0.50 | 0.47 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.03 | 0.97 | 1.20 | 1.13 | 0.91 |
Quick Ratio (X) | 0.61 | 0.56 | 0.64 | 0.58 | 0.51 |
Inventory Turnover Ratio (X) | 0.73 | 0.63 | 0.68 | 0.69 | 0.78 |
Dividend Payout Ratio (NP) (%) | 61.29 | 69.30 | 87.09 | 27.03 | 59.45 |
Dividend Payout Ratio (CP) (%) | 41.19 | 44.21 | 47.02 | 17.72 | 36.28 |
Earning Retention Ratio (%) | 38.71 | 30.70 | 12.91 | 72.97 | 40.55 |
Cash Earning Retention Ratio (%) | 58.81 | 55.79 | 52.98 | 82.28 | 63.72 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 9.69 | 8.66 | 10.30 | 7.19 | 5.08 |
Interest Coverage Ratio (Post Tax) (%) | 5.43 | 4.73 | 5.95 | 4.55 | 3.27 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 91136.90 | 56758.99 | 50939.27 | 47229.23 | 37065.09 |
EV / Net Operating Revenue (X) | 8.50 | 5.90 | 5.99 | 5.90 | 4.67 |
EV / EBITDA (X) | 26.60 | 19.66 | 19.38 | 18.62 | 16.17 |
MarketCap / Net Operating Revenue (X) | 8.21 | 5.41 | 5.56 | 5.37 | 4.20 |
Retention Ratios (%) | 38.70 | 30.69 | 12.90 | 72.96 | 40.54 |
Price / BV (X) | 12.84 | 8.39 | 7.95 | 7.37 | 6.92 |
Price / Net Operating Revenue (X) | 8.21 | 5.41 | 5.56 | 5.37 | 4.20 |
EarningsYield | 0.01 | 0.02 | 0.01 | 0.02 | 0.03 |